Kate Dominguez > Gibson, Dunn & Crutcher LLP > New York, United States > Lawyer Profile

Gibson, Dunn & Crutcher LLP
200 PARK AVENUE
NEW YORK, NY 10166-0193
NEW YORK
United States
Kate Dominguez photo

Work Department

Intellectual Property.

Position

Kate has extensive experience litigating complex patent cases from discovery through trial and appeal, and has worked across a broad spectrum of technologies, including both high-tech and life sciences matters. Representative technologies she has litigated include systems and software for data storage, encryption, interactive television, intrusion detection, mobile communications, network authentication, and wireless networking, among others. Kate’s life sciences work has included matters relating to recombinant DNA, pharmaceutical composition and dosing, and medical devices. Her practice also includes antitrust litigation in which a client’s defense of its intellectual property rights gives rise to antitrust allegations.

Career

For more information, please visit https://www.gibsondunn.com/lawyer/dominguez-kate/.

Lawyer Rankings

United States > Intellectual property > Patents: litigation (full coverage)

The intellectual property group at Gibson, Dunn & Crutcher LLP is highly adept at handling high-value and complex cases, frequently representing pharma companies in cases involving billion-dollar drugs and using the wide range of technical expertise available in the team to excel in telecoms-related cases. The group works closely with the appellate and constitutional law group at the firm, with appellate litigators often brought into develop legal strategy. The firm counts a number of household names as clients including Fitbit, Dell, Pfizer, AT&T, SoundCloud, and SharkNinja. All based in New York, Jane Love, Kate Dominguez, and Josh Krevitt all co-chair the intellectual property practice, alongside Ernest Hsin, operating out of the San Francisco office. The team continues to grow, with Charlotte Jacobsen joining the New York office from Ropes & Gray LLP in April 2022.